Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago
Abstract
:1. Introduction
2. Materials and Methods
- Non-communicable disease: Respondents were asked to self-identify with the statement “A person with a chronic illness or pre-existing health condition”.
- Concerns related to COVID-19—This comprised a list of 27 concerns relating to the COVID-19 pandemic, including fear of infection, impact on work, childcare, domestic violence, overall health and wellbeing, social isolation, public health restrictions, economy, and vaccines. Respondents were asked to select all the concerns they had (Yes/No) and were also able to record other concerns not listed.
- Behavioural changes—Respondents were asked to record changes in health habits on a 5 point Likert scale—a lot more, a little more, no difference, a little less, and a lot less, compared to before the COVID-19 pandemic. Behavioural health habits included amount of food eaten, amount of exercise, change in sleep pattern, and amount of alcohol, nicotine, and marijuana consumed.
- Mental health assessment—Core signs and symptoms of anxiety disorder over the prior two weeks were assessed using the ultra-brief four-item Patient Health Questionnaire (PHQ). A score of 3 or greater on either the anxiety or depression sub-scale was accepted as the cut-off point for identifying possible cases of depression or anxiety disorder. PHQ scores range from mild (PHQ score = 3–5) to moderate (PHQ score = 6–8) to severe (PHQ score = 9–12).
Statistical Analysis
3. Results
3.1. Prevalence of NCDs
3.2. Concerns about COVID-19
3.3. Impact of COVID-19 on Persons with and without NCDs
3.4. COVID-19 Related Changes in Health Behaviour
3.5. Anxiety and Depression
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Chadee, D.; Seemungal, T.; Pereira, L.M.P.; Chadee, M.; Maharaj, R.; Teelucksingh, S. Prevalence of self-reported diabetes, hypertension and heart disease in individuals seeking State funding in Trinidad and Tobago, West Indies. J. Epidemiol. Glob. Health 2013, 3, 95–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pan American STEPS. Chronic Non-Communicable Disease Risk Factor Survey, Trinidad and Tobago, Final Report—2012; PAHO, Ministry of Health: Port-of-Spain, Trinidad and Tobago, 2012.
- Gold, J.A.W.; Wong, K.K.; Szablewski, C.M.; Patel, P.R.; Rossow, J.; da Silva, J.; Natarajan, P.; Morris, S.B.; Fanfair, R.N.; Rogers-Brown, J.; et al. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19—Georgia, March 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 545–550. [Google Scholar] [CrossRef] [PubMed]
- Ma, C.; Gu, J.; Hou, P.; Zhang, L.; Bai, Y.; Guo, Z.; Wu, H.; Zhang, B.; Li, P.; Zhao, X. Incidence, Clinical Characteristics and Prognostic Factor of Patients with COVID-19: A Systematic Review and Meta-analysis. medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Ozamiz-Etxebarria, N.; Dosil-Santamaria, M.; Picaza-Gorrochategui, M.; Idoiaga-Mondragon, N. Stress, Anxiety, and Depression Levels in the Initial Stage of the COVID-19 Outbreak in a Population Sample in the Northern Spain. Cad. Saude Publica 2020, 36, 1–9. [Google Scholar] [CrossRef]
- Mazza, C.; Ricci, E.; Biondi, S.; Colasanti, M.; Ferracuti, S.; Napoli, C.; Roma, P. A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors. Int. J. Environ. Res. Public Health 2020, 17, 3165. [Google Scholar] [CrossRef]
- Hajure, M.; Tariku, M.; Mohammedhussein, M.; Dule, A. Depression, Anxiety and Associated Factors Among Chronic Medical Patients Amid COVID-19 Pandemic in Mettu Karl Referral Hospital, Mettu, Ethiopia, 2020. Neuropsychiatr. Dis. Treat. 2020, 16, 2511–2518. [Google Scholar] [CrossRef]
- Øversveen, E.; Eikemo, T.A. Reducing social inequalities in health: Moving from the ‘causes of the causes’ to the ‘causes of the structures’. Scand. J. Public Health 2018, 46, 1–5. [Google Scholar] [CrossRef]
- Etienne, C.F. COVID-19 has revealed a pandemic of inequality. Nat. Med. 2022, 28, 17. [Google Scholar] [CrossRef]
- Campion, J.; Javed, A.; Sartorius, N.; Marmot, M. Addressing the public mental health challenge of COVID-19. Lancet Psychiatry 2020, 7, 657–659. [Google Scholar] [CrossRef] [PubMed]
- Rossell, S.L.; Neill, E.; Phillipou, A.; Tan, E.J.; Toh, W.L.; Van Rheenen, T.E.; Meyer, D. An overview of current mental health in the general population of Australia during the COVID-19 pandemic: Results from the COLLATE project. Psychiatry Res. 2021, 296, 113660. [Google Scholar] [CrossRef]
- Kroenke, K.; Spitzer, R.L.; Williams, J.B.W.; Lo€we, B. An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics 2009, 50, 613–621. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fraser, L.; Burnell, M.; Salter, L.C.; Fourkala, E.-O.; Kalsi, J.; Ryan, A.; Gessler, S.; Gidron, Y.; Steptoe, A.; Menon, U. Identifying hopelessness in population research: A validation study of two brief measures of hopelessness. BMJ Open 2014, 4, e005093. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Harris, P.A.; Taylor, R.; Thielke, R.; Payne, J.; Gonzalez, N.; Conde, J.G. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009, 42, 377–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Motilal, S.; Khan, R.; Bernard, G.S.; Ivey, M.A.; Reid, S.D. Positive influences of the COVID-19 pandemic on community dwelling adults in Trinidad and Tobago: A cross sectional study. J. Ment. Health, 2022; Epub ahead of print. [Google Scholar] [CrossRef]
- Steel, Z.; Marnane, C.; Iranpour, C.; Chey, T.; Jackson, J.W.; Patel, V.; Silove, D. The global prevalence of common mental disorders: A systematic review and meta-analysis 1980–2013. Int. J. Epidemiol. 2014, 43, 476–493. [Google Scholar] [CrossRef] [Green Version]
- Maharaj, R.; Reid, S.; Misir, A.; Simeon, D. Depression and its associated factors among patients attending chronic disease clinics in southwest Trinidad. West Indian Med. J. 2005, 54, 369–374. [Google Scholar] [CrossRef]
- Maharaj, R.G. Depression and type 2 diabetes mellitus: What we can learn from the Trinidad and Tobago experience. Ment. Health Fam. Med. 2011, 8, 133–136. [Google Scholar] [PubMed]
- Frederick, F.; Maharajh, H. Prevalence of Depression in Type 2 Diabetic Patients in Trinidad and Tobago. West Indian Med. J. 2014, 62, 628–631. [Google Scholar] [CrossRef] [Green Version]
- Ali, S. Depression and Diabetic Control amongst a Chronic Disease Clinic in Trinidad. A Clinical Research Project submitted in partial fulfillment of the requirements for the Degree of Doctorate of Medicine: Family Medicine; The University of the West Indies: St. Augustine, FL, USA, 2018. [Google Scholar]
- Abuhasira, R.; Haviv, Y.S.; Leiba, M.; Leiba, A.; Ryvo, L.; Novack, V. Cannabis is associated with blood pressure reduction in older adults—A 24-hours ambulatory blood pressure monitoring study. Eur. J. Intern. Med. 2021, 86, 79–85. [Google Scholar] [CrossRef]
- Kalla, A.; Krishnamoorthy, P.M.; Gopalakrishnan, A.; Figueredo, V.M. Cannabis use predicts risks of heart failure and cerebrovascular accidents: Results from the national inpatient sample. J. Cardiovasc. Med. 2018, 19, 480–484. [Google Scholar] [CrossRef]
- Subramaniam, V.N.; Menezes, A.R.; DeSchutter, A.; Lavie, C.J. The Cardiovascular Effects of Marijuana: Are the Potential Ad-verse Effects Worth the High? MoMed 2019, 116, 146–153. [Google Scholar]
- Jarjou’I, A.; Izbicki, G. Medical Cannabis in Asthmatic Patients. Isr. Med. Assoc. J. 2020, 22, 232–235. [Google Scholar] [PubMed]
- Porr, C.J.; Rios, P.; Bajaj, H.S.; Egan, A.M.; Huot, C.; Batten, R.; Bishop, L.; Ryan, D.; Davis, E.; Darvesh, N.; et al. The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: A rapid review. Syst. Rev. 2020, 9, 187. [Google Scholar] [CrossRef]
- Moussavi, S.; Chatterji, S.; Verdes, E.; Tandon, A.; Patel, V.; Ustun, B. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet 2007, 370, 851–858. [Google Scholar] [CrossRef] [PubMed]
- Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.; Wang, H.; Wang, Y.; Zhou, Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020, 94, 91–95. [Google Scholar] [CrossRef]
- Pécout, C.; Pain, E.; Chekroun, M.; Champeix, C.; Kulak, C.; Prieto, R.; van Vugt, J.; Gilchrist, K.; Lainé-Pellet, A.-F. Impact of the COVID-19 Pandemic on Patients Affected by Non-Communicable Diseases in Europe and in the USA. Int. J. Environ. Res. Public Health 2021, 18, 6697. [Google Scholar] [CrossRef]
- Balhara, Y.P.S.; Anwar, N.; Kuppili, P.P. Depression and physical noncommunicable diseases: The need for an integrated approach. WHO South-East Asia J. Public Health 2017, 6, 12–17. [Google Scholar] [CrossRef] [Green Version]
- Bambra, C.; Riordan, R.; Ford, J.; Matthews, F. The COVID-19 pandemic and health inequalities. J. Epidemiol. Community Health 2020, 74, 964–968. [Google Scholar] [CrossRef]
Chronic Disease (N *) | Yes | % |
---|---|---|
Hypertension (N = 1221) | 193 | 15.8 |
Asthma (N = 1182) | 175 | 14.8 |
Diabetes (N = 1202) | 92 | 7.7 |
Cardiac disease (N = 1158) | 43 | 3.7 |
Cancer (N = 1135) | 38 | 3.2 |
Chronic Obstructive Pulmonary Disease/emphysema (N = 1149) | 9 | 0.8 |
HIV (N = 1146) | 6 | 0.5 |
Demographic | Persons with NCDs | p-Value | |
---|---|---|---|
No (n = 1067) | Yes (n = 219) | ||
Age (years) | |||
18–24 | 255 (23.9%) | 16 (7.3%) | <0.001 † |
25–39 | 344 (32.2%) | 51 (23.2%) | 0.008 † |
40–54 | 302 (28.3%) | 92 (41.8%) | <0.001 † |
55–75 | 161 (15.1%) | 60 (27.3%) | <0.001 † |
>76 | 5 (0.5%) | 1 (0.5%) | 0.999 * |
Sex | |||
Male | 547 (51.3%) | 85 (38.6%) | <0.001 † |
Female | 514 (48.2%) | 132 (60.0%) | 0.001 † |
Other | 6 (0.6%) | 3 (1.4%) | 0.188 |
Ethnicity | 0.758 * | ||
African | 397 (37.2%) | 84 (38.4%) | |
East Indian | 406 (38.1%) | 71 (32.4%) | |
Other | 264 (24.7%) | 64 (29.2%) |
Ranked Concerns of Persons with NCDs (N = 219) | Yes | % | * adjOR (95% CI) | p Value |
---|---|---|---|---|
| 132 | 60.3 | 1.54 (1.14–2.09) | 0.005 |
| 132 | 60.3 | 0.81 (0.59–1.10) | 0.179 |
| 128 | 58.4 | 1.049 (0.77–1.42) | 0.760 |
| 128 | 58.4 | 1.59 (1.17–2.15) | 0.003 |
| 121 | 55.3 | 0.82 (0.61–1.11) | 0.195 |
| 116 | 53.0 | 0.85 (0.63–1.15) | 0.293 |
| 115 | 52.5 | 1.11 (0.83–1.51) | 0.468 |
| 109 | 49.8 | 0.91 (0.67–1.22) | 0.516 |
| 108 | 49.3 | 1.05 (0.78–1.42) | 0.750 |
| 106 | 48.4 | 0.85 (0.63–1.14) | 0.270 |
| 96 | 43.8 | 0.75 (0.55–1.01) | 0.057 |
| 91 | 41.6 | 1.81 (1.33–2.46) | <0.001 |
| 81 | 37.0 | 1.06 (0.77–1.46) | 0.714 |
| 78 | 35.6 | 1.14 (0.82–1.56) | 0.430 |
| 77 | 35.2 | 1.55 (1.13–2.15) | 0.008 |
| 75 | 34.2 | 1.01 (0.73–1.38) | 0.962 |
| 75 | 34.2 | 1.48 (1.08–2.05) | 0.017 |
| 74 | 33.8 | 0.78 (0.56–1.06) | 0.114 |
| 69 | 31.5 | 1.10 (0.80–1.03) | 0.559 |
| 56 | 25.6 | 1.15 (0.81–1.64) | 0.433 |
| 50 | 22.8 | 0.89 (0.63–1.27) | 0.533 |
| 48 | 21.9 | 0.92 (0.64–1.33) | 0.659 |
| 47 | 21.5 | 1.25 (0.85–1.82) | 0.252 |
| 37 | 16.9 | 0.74 (0.50–1.09) | 0.131 |
| 33 | 15.1 | 1.34 (0.87–2.06) | 0.186 |
| 15 | 6.8 | 0.47 (0.27–0.83) | 0.009 |
| 4 | 1.8 | 0.37 (0.12–1.15) | 0.085 |
| 1 | 0.5 | 0.25 (0.03–1.91) | 0.181 |
Select Variables | Prevalence among Those | * adjROR (95% CI) | p Value | |
---|---|---|---|---|
With No NCDs | With NCDs | |||
Employment Status Before Pandemic | ||||
Employed full time/part time | 664 (63.0%) | 147 (68.1%) | 1 | |
Student full time/part time | 211 (20.0%) | 14 (6.5%) | 0.65 (0.28–1.47) | 0.299 |
Unemployed | 64 (6.1%) | 19 (8.8%) | 1.61 (0.93–2.81) | 0.091 |
Homemaker/volunteer/retired | 115 (10.9%) | 36 (16.7%) | 0.80 (0.48–1.34) | 0.393 |
Current Employment Status | ||||
Employed full time/part time | 601 (56.9%) | 117 (53.7%) | 1 | |
Student full time/part time | 179 (17.0%) | 12 (5.5%) | 0.68 (0.29–1.60) | 0.381 |
Unemployed | 167 (15.8%) | 44 (20.2%) | 1.49 (1.01–2.22) | 0.047 |
Homemaker/volunteer/retired | 109 (10.3%) | 45 (20.3%) | 1.41 (0.86–2.30) | 0.171 |
Job Loss Due to Pandemic | ||||
No | 86 (52.4%) | 22 (50.0%) | 1 | |
No but reduced hours | 21 (12.8%) | 2 (4.5%) | 0.20 (0.04–1.03) | 0.054 |
No but job loss expected | 12 (7.3%) | 1 (2.3%) | 0.26 (0.03–2.32) | 0.226 |
Yes | 45 (27.4%) | 19 (43.2%) | 1.34 (0.63–2.86) | 0.442 |
Social Contact with Others (Not Family or Co-Workers) In a typical week, before the COVID-19 pandemic, how much time would you have spent with people who do not live with you (not related to work)? | ||||
No time | 69 (6.6%) | 21 (9.6%) | 1 | |
Less than ½ h daily | 165 (15.7%) | 37 (17.0%) | 0.71 (0.38–1.32) | 0.281 |
½ h–1 h daily | 196 (18.6%) | 46 (21.1%) | 0.74 (0.40–1.36) | 0.329 |
1 h–2 h daily | 160 (15.2%) | 38 (17.4%) | 0.66 (0.35–1.23) | 0.191 |
More than 2 h daily | 463 (44.0%) | 76 (34.9%) | 0.64 (0.36–1.13) | 0.125 |
Social Contact with Others (Not Family or Co-Workers) In the last week, how much time have you spent each day in contact with people who do not live with you (not related to work)? | ||||
No time | 152 (14.4%) | 51 (23.4%) | 1 | |
Less than ½ h daily | 259 (24.5%) | 48 (22.0%) | 0.51 (0.33–0.81) | 0.004 |
½ h–1 h daily | 282 (26.7%) | 51 (23.4%) | 0.55 (0.35–0.86) | 0.009 |
1 h–2 h daily | 199 (18.8%) | 33 (15.1%) | 0.49 (0.30–0.81) | 0.005 |
More than 2 h daily | 164 (15.5%) | 35 (16.1%) | 0.63 (0.38–1.04) | 0.069 |
Self-Reported Negative Mental Effects of Government Restrictions | ||||
Not at all | 454 (43.2%) | 94 (43.3%) | 1 | |
Very positively | 81 (7.7%) | 11 (5.1%) | 0.56 (0.29–1.11) | 0.099 |
Somewhat positively | 175 (16.7%) | 27 (12.4%) | 0.86 (0.54–1.39) | 0.547 |
Somewhat negatively | 304 (29.0%) | 68 (31.3%) | 1.40 (0.98–2.02) | 0.066 |
Very negatively | 36 (3.4%) | 17 (7.8%) | 2.97 (1.55–5.66) | 0.001 |
Health Behaviours | Persons with an NCD | * adjROR (95% CI) | p Value | |
---|---|---|---|---|
No (n = 1067) | Yes (n = 219) | |||
Amount you Eat Daily | ||||
No change | 184 (17.5%) | 50 (23.4%) | 1 | |
More | 607 (57.0%) | 98 (45.8%) | 0.72 (0.49–1.06) | 0.097 |
Less | 260 (24.7%) | 66 (30.8%) | 1.30 (0.84–2.01) | 0.232 |
Exercise Daily | ||||
No change | 298 (28.2%) | 57 (26.8%) | 1 | |
More | 290 (27.5%) | 48 (22.5%) | 1.03 (0.67–1.59) | 0.881 |
Less | 467 (44.3%) | 108 (50.7%) | 1.38 (0.96–1.99) | 0.079 |
Sleep Daily | ||||
No change | 284 (26.8%) | 52 (23.7%) | 1 | |
More | 461 (43.6%) | 100 (45.7%) | 1.80 (1.21–2.67) | 0.003 |
Less | 313 (29.6%) | 67 (30.6%) | 1.41 (0.94–2.12) | 0.102 |
Weekly Alcoholic Drink BEFORE Lockdown | ||||
I do not drink | 503 (47.6%) | 113 (51.6%) | 1 | |
<10 standard drinks /week | 521 (49.3%) | 102 (46.6%) | 0.88 (0.65–1.19) | 0.401 |
>10 standard drinks/week | 32 (3.0%) | 4 (1.8%) | 0.48 (0.15–1.49) | 0.202 |
Alcohol Drinking Change | ||||
No change | 597 (63.2%) | 111 (56.1%) | 1 | |
More | 139 (14.7%) | 33 (16.7%) | 1.52 (0.98–2.38) | 0.064 |
Less | 208 (22.0%) | 54 (27.3%) | 1.40 (0.96–2.05) | 0.078 |
Nicotine Use BEFORE Lockdown | ||||
I do not use nicotine | 970 (92.4%) | 193 (91.0%) | 1 | |
<3 times/week | 13 (1.2%) | 2 (0.9%) | 0.88 (0.18–4.24) | 0.874 |
>3 times/week | 67 (6.4%) | 17 (8.0%) | 1.13 (0.62–2.04) | 0.694 |
Nicotine Use Change DURING Lockdown | ||||
No change | 702 (91.1%) | 136 (92.5%) | 1 | |
More | 49 (6.4%) | 4 (2.7%) | 0.48 (0.20–1.18) | 0.109 |
Less | 20 (2.6%) | 7 (4.8%) | 2.48 (1.01–6.06) | 0.047 |
Marijuana use BEFORE lockdown | ||||
I do not use marijuana | 910 (86.1%) | 205 (94.9%) | 1 | |
<3 times/week | 101 (9.6%) | 7 (3.2%) | 0.46 (0.20–1.10) | 0.082 |
>3 times/week | 46 (4.4%) | 4 (1.9%) | 0.66 (0.23–1.91) | 0.443 |
Marijuana frequency change DURING lockdown | ||||
No change | 676 (87.2%) | 128 (87.1%) | 1 | |
More | 43 (5.5%) | 16 (10.9%) | 3.31 (1.81–6.06) | <0.001 |
Less | 56 (7.2%) | 3 (2.0%) | 0.97 (0.41–2.33) | 0.953 |
Factors | PHQ-4 Anxiety/Depression Score * | adjROR Ϯ | 95% CI | p Value | |||
---|---|---|---|---|---|---|---|
Not Severe | Severe | ||||||
n | % | n | % | ||||
Employment Status before Pandemic | |||||||
Employed | 118 | 74.7 | 26 | 48.1 | 1 | ||
Unemployed/Student/ Homemaker/Retired | 40 | 25.3 | 28 | 51.9 | 4.42 | (2.16, 9.04) | <0.001 |
Job Loss due to Pandemic | |||||||
No change | 6 | 33.3 | 19 | 73.1 | 1 | ||
Lost job | 12 | 66.7 | 7 | 29.9 | 0.19 | (0.05, 0.76) | 0.019 |
Social Isolation | |||||||
No | 139 | 85.8 | 23 | 41.8 | 1 | ||
Yes | 23 | 14.2 | 32 | 58.2 | 8.48 | (4.06, 17.71) | <0.001 |
Self-Reported Change in Mental Effects from Government Restrictions | |||||||
No Change | 88 | 55 | 6 | 11.1 | 1 | ||
Positive | 20 | 12.5 | 16 | 29.6 | 12.04 | (4.03, 35.96) | <0.001 |
Negative | 52 | 32.5 | 32 | 59.3 | 6.35 | (2.39, 16.89) | <0.001 |
Self-Reported Change in Mental Effects from Government Restrictions | |||||||
No Change/Positive | 108 | 67.5 | 22 | 40.7 | 1 | ||
Negative | 52 | 32.5 | 32 | 59.3 | 2.11 | (1.07, 4.18) | 0.032 |
Alcohol drinking change | |||||||
No Change | 75 | 52.1 | 35 | 68.6 | 1 | ||
More | 27 | 18.8 | 5 | 9.8 | 0.21 | (0.07, 0.65) | 0.007 |
Less | 42 | 29.2 | 11 | 21.6 | 0.39 | (0.16, 0.95) | 0.038 |
Alcohol drinking change | |||||||
No Change/Less | 117 | 81.3 | 45 | 90.0 | 1 | ||
More | 27 | 18.8 | 5 | 10.0 | 0.30 | (0.11, 0.88) | 0.028 |
Marijuana Use Change Lockdown | |||||||
No Change | 85 | 87.6 | 40 | 90.9 | 1 | ||
More | 12 | 12.4 | 4 | 9.1 | 0.19 | (0.04, 0.79) | 0.022 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Reid, S.D.; Motilal, S.; Pooransingh, S.; St. Bernard, G.; Ivey, M.A. Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago. Int. J. Environ. Res. Public Health 2023, 20, 6543. https://doi.org/10.3390/ijerph20166543
Reid SD, Motilal S, Pooransingh S, St. Bernard G, Ivey MA. Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago. International Journal of Environmental Research and Public Health. 2023; 20(16):6543. https://doi.org/10.3390/ijerph20166543
Chicago/Turabian StyleReid, Sandra D., Shastri Motilal, Shalini Pooransingh, Godfrey St. Bernard, and Marsha A. Ivey. 2023. "Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago" International Journal of Environmental Research and Public Health 20, no. 16: 6543. https://doi.org/10.3390/ijerph20166543
APA StyleReid, S. D., Motilal, S., Pooransingh, S., St. Bernard, G., & Ivey, M. A. (2023). Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago. International Journal of Environmental Research and Public Health, 20(16), 6543. https://doi.org/10.3390/ijerph20166543